Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE® (verteporfin for injection), for intravenous use Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
VISUDYNE® (verteporfin for injection) therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration (AMD), pathologic myopia or presumed ocular histoplasmosis. There is insufficient evidence to indicate VISUDYNE for the treatment of predominantly occult subfoveal CNV.
- generic_name
- verteporfin for injection
- product_names
- verteporfin for injection
- ndc
- 24208-560, 24208-560-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en